Skip to main content
PepStack
Blutwerte · Marker

ACTH

Adrenocorticotropin · Adrenocorticotropes Hormon · Corticotropin

Hormone — StressachseZeitabhängig
Einheit:
pg/mL

ACTH quantifies the level of adrenocorticotropic hormone in the blood, reflecting pituitary function and adrenal stimulation.

Reference Ranges

Reference
10–60pg/mL
10
60
LowNormalHigh
Reference
Unit · pg/mL

ACTH levels are subject to diurnal variation, peaking in the early morning.

Overview

Übersicht

Adrenocorticotropic hormone (ACTH) is a peptide hormone produced by the anterior pituitary gland. It plays a crucial role in the hypothalamic-pituitary-adrenal (HPA) axis, stimulating the adrenal cortex to release glucocorticoids, primarily cortisol, which are vital for stress response, metabolism, and immune function. Clinically, ACTH levels are significant in diagnosing and differentiating conditions such as Cushing's syndrome, Addison's disease, and secondary adrenal insufficiency. Elevated ACTH levels can indicate ACTH-dependent Cushing's syndrome, while low levels may suggest adrenal tumors or exogenous steroid use. For athletes and biohackers, understanding ACTH and its effects on cortisol can be critical for optimizing stress responses and recovery. However, ACTH levels can be influenced by various factors, including time of day, stress, and medications, necessitating careful interpretation of test results. Researchers have found that ACTH levels exhibit diurnal variation, peaking in the early morning and declining throughout the day, which should be considered when scheduling tests.

Klinische Bedeutung

Elevated ACTH levels may indicate Cushing's disease or ectopic ACTH syndrome, while reduced levels can suggest adrenal insufficiency or pituitary dysfunction.

Dynamics

Trend Interpretation

Rising Values

Progressively rising ACTH values may suggest worsening of Cushing's disease or ectopic ACTH production. Re-test in 4 weeks if outside the optimal range.

Falling Values

Progressively falling ACTH values may indicate adrenal recovery or response to treatment.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Cushing's disease
  • Ectopic ACTH syndrome
  • Adrenal insufficiency
  • Stress
  • Hypoglycemia
Cause

Low Levels

  • Adrenal tumors
  • Exogenous steroid use
  • Pituitary dysfunction
  • Secondary adrenal insufficiency
  • Hypopituitarism
Protocol

How to Optimize

Lever

Lifestyle

  • Stress management techniques
  • Regular physical activity
  • Adequate sleep
Lever

Nutrition

  • Balanced diet rich in whole foods
  • Adequate hydration

Note:

Consult a healthcare provider before making significant lifestyle or dietary changes.

Testing Guidelines

✓Fasting Not Required
🕐Time-Sensitive

ACTH peaks at 8am; draw at the same time for comparability.

Testing Frequency

Annually for those with adrenal disorders or as needed based on symptoms.

Interfering Factors

  • Recent intense exercise
  • Stress
  • Medications affecting cortisol

Related Peptides & Hormones

Cortisol

Directly measures

hormone

Open Research Questions

Current research suggests that the relationship between salivary cortisol and plasma ACTH levels is not linear, indicating potential confounders in stress research that remain understudied. Researchers have not yet established optimal reference ranges for ACTH in various clinical contexts, particularly in differentiating between Cushing's disease and melancholic depression. Additionally, unanswered clinical questions include the precise mechanisms by which psychological stressors influence ACTH and cortisol responses across different populations.

42 Research Publications

8,565

Total Citations

5

Human/RCT

58.2

Avg. Influence

2023

Latest

Sort
Filter
#01

Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research.

Meta-AnalysisInfluence488.0
5931
This meta-analysis reviewed 208 studies on psychological stressors and cortisol responses. Researchers found that uncontrollable tasks with social-evaluative threat elicited the largest cortisol and ACTH changes. The findings challenge the notion that cortisol responds similarly to all stressors.
View on PubMed
#02

Salivary cortisol as a biomarker in stress research.

ReviewInfluence51.0
1905
This study explored salivary cortisol as a biomarker for stress. Researchers observed that salivary cortisol measures may not directly correlate with plasma ACTH and cortisol levels due to various biological factors affecting the hypothalamus-pituitary-adrenal axis.
View on PubMed
#03

Pathophysiology of hypercortisolism in depression.

UnknownInfluence21.0
267
This study investigated the dynamics of ACTH and cortisol in depressed patients, finding that hypercortisolemia is associated with melancholic and psychotic subtypes. Researchers noted increased ACTH secretion regardless of cortisol levels, indicating central HPA axis overdrive in severe depression.
View on PubMed
#04

Response of the hypothalamo-pituitary-adrenal axis to nicotine.

ReviewInfluence13.0
145
Researchers reviewed the effects of nicotine on ACTH secretion, finding that nicotine stimulates the HPA axis through central mechanisms. The study highlighted the role of brainstem catecholaminergic pathways in mediating this response, suggesting a complex interaction.
View on PubMed
#05

Canine hypoadrenocorticism: pathogenesis, diagnosis, and treatment.

ReviewInfluence4.0
59
This study examined hypoadrenocorticism in dogs, a condition caused by immune-mediated destruction of adrenal glands. Researchers found that definitive diagnosis requires ACTH stimulation testing to demonstrate low cortisol levels. The prognosis is good with appropriate supplementation.
View on PubMed
#06

Cushing's disease.

Review
57
This study focused on Cushing's disease, characterized by ACTH hypersecretion from the pituitary. Researchers noted that the initial diagnosis involves documenting hypercortisolism, followed by identifying the cause, typically through selective transsphenoidal resection.
View on PubMed
#07

Peripheral and prefrontal stress system markers and risk of relapse in alcoholism.

Human
42
This study assessed stress system markers in alcohol-dependent patients. Researchers found that a high cortisol to ACTH ratio during neutral states predicted relapse risk, indicating its potential as a peripheral marker of brain dysfunction.
View on PubMed
#08

Cushing syndrome: update on testing.

Review
35
This review provided an update on the diagnosis of Cushing syndrome. Researchers highlighted the importance of late-night salivary cortisol and prolactin measurement in distinguishing between types of ACTH-dependent Cushing syndrome.
View on PubMed
#09

Circulating microRNA Expression in Cushing's Syndrome.

UnknownInfluence1.0
21
This study characterized circulating microRNA profiles in Cushing's syndrome patients. Researchers identified distinct profiles between ACTH-dependent and independent subtypes, with miR-182-5p being significantly upregulated in Cushing's disease, suggesting its potential as a biomarker.
View on PubMed
#10

Exogenous Cushing Syndrome Caused by a "Herbal" Supplement.

Case ReportInfluence1.0
20
Researchers reported two cases of exogenous Cushing syndrome linked to an over-the-counter herbal supplement. They found that hidden glucocorticoids in supplements can complicate diagnosis and management.
View on PubMed

Clinical Trials (15)

15

Total Trials

628

Total Enrolled

Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors.

NCT07463625RECRUITING
Sponsor

Hospices Civils de Lyon

Enrollment

20

Started

2023

Primary outcome

[18F]FET PET Performance for Localizing Corticotroph Pituitary Adenomas

Cushing DiseaseACTH-producing Pituitary Tumour

Use of CXCL9 as a Biomarker of Acthar Efficacy

NCT02523092Phase 4TERMINATED
Sponsor

University of California, San Francisco

Enrollment

2

Started

2022

Primary outcome

Number of Participants That Show a Decrease in Blood CXCL9 Levels by 50%

Sarcoidosis

Implications of Different Analgesic Models on Inflammatory Markers After Laparoscopic Cholecystectomy

NCT04609033COMPLETED
Sponsor

Assiut University

Enrollment

110

Started

2020

Primary outcome

postoperative level of ACTH hormone

Perioperative Pain

Comparison of Intramuscular and Intravenous ACTH Stimulation Test in Normal Volunteers

NCT03752190Phase 4WITHDRAWN
Sponsor

Johns Hopkins University

Enrollment

0

Started

2019

Primary outcome

peak serum cortisol

Adrenal Insufficiency

A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients

NCT05546047Phase 4UNKNOWN
Sponsor

NephroNet, Inc.

Enrollment

34

Started

2019

Primary outcome

The change in UP/CR ratio with treatment of Acthar gel 80 units subcutaneous 2 times a week alone

Fibrillary Glomerulonephritis

Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses

NCT03021317Phase 4TERMINATED
Sponsor

University of Chicago

Enrollment

5

Started

2016

Primary outcome

Change in T1 Lesion Relaxation Time

Multiple Sclerosis

Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery

NCT02922257COMPLETED
Sponsor

Corcept Therapeutics

Enrollment

26

Started

2016

Primary outcome

Gene expression levels

Cushing's Syndrome

Treatment of CNS Sarcoidosis With H.P. Acthar Gel

NCT02298491Phase 4COMPLETED
Sponsor

University of Maryland, Baltimore

Enrollment

4

Started

2016

Primary outcome

Karnofsky Performance Status (KPS) Score

CNS Sarcoidosis

The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients

NCT01948388Phase 4COMPLETED
Sponsor

Gaylis, Norman B., M.D.

Enrollment

20

Started

2013

Primary outcome

Change From Baseline in Clinical Disease Activity Index (CDAI) Score

Rheumatoid Arthritis

NeSST2: The Development of a Noninvasive Short Synacthen Test

NCT03514589Phase 2RECRUITING
Sponsor

Sheffield Children's NHS Foundation Trust

Enrollment

12

Started

2012

Primary outcome

Peak plasma cortisol concentration (Cmax)

Adrenal Suppression

Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients

NCT01601236Phase 2COMPLETED
Sponsor

Mallinckrodt

Enrollment

34

Started

2012

Primary outcome

Percent Change in Estimated Glomerular Filtration Rate (eGFR) at Visit 12

Diabetic Nephropathy

Stress Level and the Relationship With IVF Outcomes.

NCT02638662COMPLETED
Sponsor

Weill Medical College of Cornell University

Enrollment

276

Started

2010

Primary outcome

Biomarkers Cortisol and adrenocorticotropic hormone ACTH.

Infertility

Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds

NCT00704262Phase 2COMPLETED
Sponsor

LEO Pharma

Enrollment

33

Started

2008

Primary outcome

The Adrenal Response to the ACTH Challenge Test Defined as the Serum Cortisol Concentration Obtained After 30 and 60 Minutes

Psoriasis Vulgaris

Remifentanil and Stress Hormones Response

NCT03378674COMPLETED
Sponsor

Catholic University of the Sacred Heart

Enrollment

50

Started

2008

Primary outcome

ACTH levels changes

Stress Response

Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)

NCT00612066Phase 2TERMINATED
Sponsor

Jonsson Comprehensive Cancer Center

Enrollment

2

Started

2007

Primary outcome

Number of Responders

Cushing's Disease

Publication Trend

Research publications about ACTH over time

9total
1
'52
1
'87
1
'04
1
'09
1
'14
1
'15
1
'22
1
'23
1
'24

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer